Mutations in the retinoblastoma tumor suppressor gene Rb are involved in many forms of human cancer. In this study, we investigated the early consequences of inactivating Rb in the context of cellular reprogramming. We found that Rb inactivation promotes the reprogramming of © 2015 Elsevier Inc. * Correspondence: julsage@stanford.edu (J.S.), wernig@stanford.edu (M.W.). 9 Co-senior author
INTRODUCTION
The retinoblastoma gene product Rb is a potent suppressor of the tumorigenic process and is genetically or functionally inactivated in most, if not all, human cancers by direct mutation or alterations in upstream pathway members (Burkhart and Sage, 2008) . Loss of Rb function has been directly implicated in initiation of cancers, including retinoblastoma, osteosarcoma, and small cell lung carcinoma in patients, as well as pituitary and thyroid tumors in mice (Chinnam and Goodrich, 2011) . Rb controls multiple cellular functions, including proliferation, survival, differentiation, metabolism, and genomic stability, but how loss of Rb initiates cancer is still not completely understood (reviewed in Chinnam and Goodrich, 2011; Manning and Dyson, 2012; Nicolay and Dyson, 2013; Viatour and Sage, 2011) .
Induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) share some similarities to cancer cells, including the capacity to bypass senescence and form tumors upon transplantation (Goding et al., 2014) . Accordingly, some genes often associated with cancer, such as Myc (Nakagawa et al., 2008; Wernig et al., 2008) , p53 (Krizhanovsky and Lowe, 2009) , and telomerase (Batista et al., 2011; Park et al., 2008) , have been implicated in cellular reprogramming. Additionally, two reprogramming factors, Oct4 and Sox2, can be oncogenic in some cellular contexts (Hochedlinger et al., 2005; Lu et al., 2010; Rudin et al., 2012; Sarkar and Hochedlinger, 2013) .
Given previous observations that Rb could be involved in cellular dedifferentiation (Calo et al., 2010; McEvoy et al., 2011) and given the similarities between reprogramming and some aspects of tumorigenesis, we set out to identify mechanisms by which Rb suppresses dedifferentiation using iPSC reprogramming as a cellular system. We found that Rb regulates the reprogramming of fibroblasts to iPSCs. Surprisingly, this phenomenon is not due to changes in the cell cycle. Instead, Rb globally represses pluripotency networks in somatic cells, thereby rendering cells more amenable to reprogramming, including in the absence of exogenous Sox2. Importantly, pituitary hyperplasia driven by Rb loss in mice is blocked by Sox2 deletion, expanding the functional interaction between Rb and Sox2 to cancer.
reprogramming factors (4F), Oct4, Sox2, Klf4, and c-Myc. Based on the appearance of alkaline phosphatase (AP) + colonies, we saw more efficient reprogramming in Rb mutant MEFs than in WT cells, suggesting that loss of Rb facilitates reprogramming (Figures 1A and 1B) . A similar increase in AP + colonies was observed with human fibroblasts expressing shRNAs to knock down human RB (shRB) ( Figure 1A and Figure S1A available online). Because AP is not a specific marker of pluripotency, we then used Oct4-Neo R knockin MEFs in combination with Rb knockdown ( Figure S1B ) and counted neomycinresistant colonies. To avoid errors due to reseeding of daughter colonies, we performed a 96-well assay and quantified the wells that contained iPSC colonies rather than the number of colonies themselves. In this stringent assay, the reprogramming efficiency was increased in Rb-deficient cells to a similar degree to that reported in cells with a loss of p53 (Figures 1B and 1C) (Krizhanovsky and Lowe, 2009) . Notably, Rb loss decreased the plating efficiency of MEFs ( Figure S1C ), illustrating our underestimation of the efficiency of reprogramming upon Rb loss. Reprogramming was increased by multiple hairpins against Rb ( Figure 1B ) upon acute deletion of Rb in Rb lox/lox conditional knockout MEFs (cKO MEFs) after adenoviral Cre (Ad-Cre) delivery ( Figure 1D ) and after treatment with 4-hydroxytamoxifen (4OHT) in Rosa26 CreER cKO MEFs ( Figure S1D and S1E). Conversely, overexpression of Rb reduced the reprogramming efficiency ( Figure 1E ). MEFs deficient for p107 or p130, two factors closely related to Rb, showed no changes in their reprogramming efficiency ( Figure 1F ). Triple knockout MEFs for the entire Rb family (TKOs) did not reprogram to iPSCs, presumably due to an unidentified stress response that leads to increased apoptosis during reprogramming ( Figure S1F ).
To further determine the kinetics of reprogramming in the absence of Rb, we reprogrammed Oct4-GFP knockin MEFs after Rb knockdown. Colonies re-expressing endogenous Oct4 (GFP + ) appeared significantly more quickly in cells with low Rb levels ( Figure 1G ). Utilizing SSEA1 expression as an early marker of reprogramming (Brambrink et al., 2008) , we observed that Rb loss increases reprogramming as early as days 4 and 6 ( Figure 1H , Figure S1G ). To test the time requirement for the exogenous factors to trigger full reprogramming, we used Oct4-GFP;M2rtTA MEFs infected with a doxycycline (Dox)-inducible 4F lentiviral construct. After a total of 15 days and varying the length of Dox treatment, the number of GFP + iPSC colonies was counted. Decreased Rb levels led to a significant reduction in the time requirement for 4F expression to achieve reprogramming ( Figure 1I ). Together, these data demonstrate that Rb loss accelerates and enhances iPSC generation from fibroblasts, indicating that Rb normally restricts this process.
Rb Loss Does Not Accelerate the Cell Cycle during Reprogramming
One explanation for the increased reprogramming observed in Rb-deficient cells is a faster cell cycle, as in p53 mutant cells (Hanna et al., 2009 ). We determined the doubling time of control and Rb knockdown MEFs in the first 10 days of the process to avoid the confounding effects of increased proliferation due to enhanced reprogramming in Rb mutant cells. Notably, no significant change in the growth rate of the 4F-infected MEFs was observed upon Rb knockdown (Figure 2A) , as was previously observed in Rb-deficient MEFs (Dannenberg et al., 2000; Sage et al., 2000) (see below). Similarly, there was no change in the S phase fraction in the shRb-infected MEFs, although, at day 6 there was a trend to a longer G2 and shorter G1 ( Figures 2B and 2C, Figure S2A ), possibly a consequence of increased reprogramming because a shorter G1 correlates with the acquisition of pluripotency (Conklin and Sage, 2009) . Annexin V staining did not show a significant difference in apoptosis ( Figure 2D , Figure S2B ). To quantify proliferation specifically in reprogramming cells, we focused on SSEA1 + cells and used Carboxyfluorescein diacetate succinimidyl ester (CFSE) pulse-chase staining to determine the number of cell divisions after the induction of reprogramming (Koche et al., 2011) . Using an automated analysis, we confirmed that SSEA1 + cells are proliferative ( Figure S2C and S2D) and, importantly, we found no change in the number of doublings between control and Rb knockdown populations ( Figure 2E) . Thus, the enhanced reprogramming efficiency and kinetics observed in the absence of Rb cannot be simply explained by changes in cell cycle profiles.
Rb Binds to and Represses Pluripotency Genes
Next we sought to explore how the absence of the Rb protein might render MEFs more amenable to reprogramming. Because Rb is a transcriptional coregulator, we determined the consequence of Rb loss on gene expression. To this end, cKO MEFs were infected with AdCre or Ad-GFP ( Figure S3A and S3B) and infected by the 4F or an empty vector; 3 days of selection after 4F infection, the RNA was sequenced. We used k-means clustering to divide genes that change upon 4F expression, and then we further subdivided each cluster for changes by the further loss of Rb ( Figure 3A , Figures S3C and S3D , Table S1 available online). In all these clusters, loss of Rb led to changes in the expression of cell cycle genes. However, both positive (e.g., Mcm3, Pola1, and Cdk1) and negative (e.g., p107, Cdkn2c, and Brca1) cell cycle regulators were upregulated, which may explain why loss of Rb function does not promote cell division under these conditions (Figures 3A, Figure S3C and S3D). We used gene set enrichment analysis (GSEA) to determine the consequences of Rb deletion on MEF or iPSC gene sets. We found a significant enrichment for the iPSC-specific gene signature in cells without Rb compared to Rb wild-type cells upon 4F expression ( Figure 3B and Table S1 ). Interestingly, using RT-qPCR, we observed a small but significant increase in Sox2 and Oct4 expression in Rb-deficient MEFs even without 4F infection ( Figure 3C ). As expected, the absolute expression of pluripotency genes was still much lower (<0.5%) than in ESCs ( Figure 3D ). Loss of the entire Rb family did not further increase the expression of these pluripotency genes, in contrast to cell cycle genes ( Figures  1D and 3C ). Slight OCT4 and SOX2 induction was also observed in human cells in response to RB knockdown ( Figure 3E ). Flow cytometry of Sox2-GFP MEFs after acute knockdown of Rb showed that the Sox2 induction observed in bulk analysis is caused by slight induction in many cells and not strong induction in a few cells ( Figure 3F ). Thus, loss of Rb leads to a global derepression of components of the pluripotency transcriptional program, leading to only a subtle gene induction in the majority of cells.
To determine if the repressive action of Rb on pluripotency genes might be direct, we performed Rb chromatin immunoprecipitation (ChIP) assays under the same conditions as the RNA sequencing profiling. Interrogating a few selected genomic regions by ChIP-qPCR, we observed that Rb binds to the promoter regions of Sox2 and Oct4 as well as classical cell cycle genes ( Figure 4A ). Global analysis of Rb ChIP sequencing data showed that the majority of the genes identified as being bound by Rb are associated with the cell cycle and most are upregulated upon loss of Rb, consistent with its established role as a transcriptional repressor ( Figure S4A and S4B). Genome-wide data also confirmed robust Rb binding at the Sox2 and Oct4 loci ( Figure 4B , Table S2 ). Moreover, we found Rb binding to the regulatory regions of a number of genes involved in reprogramming and pluripotency, an observation supported by the analysis of human Rb ChIP sequencing data sets (Chicas et al., 2010) ( Figure S4C ). Remarkably, at the Sox2 locus, Rb was primarily bound to the downstream enhancer (SRR2; Figure 4B and Figure S4D ), the active enhancer in pluripotent lineages (Tomioka et al., 2002) .
We next sought to determine if binding of Rb to pluripotency genes might play a role in a developmental context. When we examined expression data of both wild-type and Rb family mutant mouse ESCs before and after differentiation into embryoid bodies (EBs), we found a significant defect in the silencing of pluripotency genes (listed in Figure S4C ) upon differentiation ( Figures 4C and 4D ). Additionally, Rb progressively binds to both Oct4 and Sox2 during EB differentiation, correlating with their silencing ( Figure 4E ). Together, these experiments indicate that the binding of Rb to pluripotency factors, including Sox2 and Oct4, may both contribute to their silencing in differentiated cells and restrict their reexpression during the reprogramming process.
Because Rb typically requires a binding partner to be recruited to DNA, we sought to investigate how Rb is localized to pluripotency genes. Previous studies have suggested that E2F proteins bind to Sox2 and Oct4 (Julian et al., 2013; Xu et al., 2007) . To explore if direct interactions between Rb and E2Fs at these loci were involved in gene repression, we used MEFs in which mutations at either the E2F-binding pocket (ΔG allele) or the LxCxEbinding cleft (ΔL allele) were knocked in to the endogenous Rb locus ( Figure 4F ) (Isaac et al., 2006; Talluri et al., 2010) . We found a specific increase in the reprogramming efficiency of DG mutants ( Figure 4G ), correlating with increased levels of Oct4 and Sox2 ( Figure 4H ), similar to Rb deletion ( Figure 3C ). Thus, interactions through the E2F-binding pocket are required for the silencing of pluripotency genes by Rb.
Rb Contributes to the Maintenance of the Chromatin State at Pluripotency Genes in Fibroblasts
Based on these observations and the known interactions between Rb and regulators of chromatin structure (Longworth and Dyson, 2010) , we determined whether loss of Rb function affects the chromatin at pluripotency genes. At both Oct4 and Sox2, we observed a significant increase in the acetylation of histone H3 (H3Ac) in the proximal promoter regions upon loss of Rb ( Figure S5A ). The extent of this increase was similar to what we observed for Rb canonical targets such as Ccna2 ( Figure S5A ). However, H3K4me3 was not increased at the Oct4 or Sox2 promoter, unlike at Ccna2, which may reflect the difference between enhanced gene activation of an already expressed E2F target upon Rb loss and the slight increase of basal transcription that we observed for Oct4 and Sox2 ( Figures 3C and  3D ). Additionally, we found a significant loss of H3K27me3 at Oct4 ( Figure S5A ).
Using ChIP sequencing to gain a genome-wide perspective on histone changes upon Rb loss, we detected significantly increased levels of both H3Ac and H4K4me3 and a decrease of H3K27me3 at multiple pluripotency genes, including Oct4, Nanog, and Sox2 ( Figure 5A , Figure S5B ). Increased activating marks including H3Ac and H3K4me3 were highly correlated ( Figure S5C ) and found predominantly at cell cycle genes and known Rb targets such as p107 ( Figure 5A , Table S3 ); however, increased activating marks were also observed at both Sox2 and Nanog ( Figure 5A) . Notably, the region with increased H3Ac and H3K4me3 downstream of Sox2 is not the SRR2 enhancer, but rather a region that is bound by both p300 and CTCF and can interact with the SRR2 enhancer (Dixon et al., 2012) . GSEA indicated that an iPSC-specific gene set is significantly enriched among the genes that gain H3Ac and H3K4me3 to a similar degree as a gene set specific for Rb loss ( Figure  5B ).
A recent study described the existence of broad H3K4me3 domains that mark genes essential for cell identity and function (Benayoun et al., 2014) . We observed a change in broad domain organization upon loss of Rb ( Figure 5C , Figures S5D and S5E) . Strikingly, an unbiased analysis of genes that showed increased H3K4me3 domain breadth showed that these genes were enriched to be direct transcriptional targets of the core pluripotency network (e.g., OCT4 and NANOG; Table S3 ). The same enrichment for transcriptional targets of OCT4, SOX2, KLF4, NANOG, and TCF3 was observed in Rb-deficient cells when we analyzed increases in H3K4me3 breadth specifically in the set of H3K4me3-marked genes ( Figure 5D ). Peaks broadened by loss of Rb were domains more likely to be in the top 5% broadest domains in mouse ESCs ( Figures 5E and 5F ). Thus, the absence of Rb in MEFs generates a chromatin landscape that more closely resembles that of an ESC. Thus, Rb loss not only leads to derepression of some core pluripotency genes, but also specifically alters the chromatin of downstream targets for these pluripotency factors, possibly facilitating the transcription of a global pluripotency program and its implementation.
The silencing of chromatin at key pluripotency genes by Rb is consistent with the known interactions of Rb with key repressors (Longworth and Dyson, 2010) . To interrogate the recruitment of such factors to Oct4 and Sox2, we performed ChIP experiments in Rb wildtype and mutant MEFs. These experiments showed a strong correlation between cofactor recruitment and the histone mark changes observed. As mentioned above, Rb loss decreased H3K27me3 at a region spanning the distal enhancers to the promoter of Oct4 ( Figure 5A ), which correlated with a decrease of EZH2 recruitment to this region ( Figure 5G ). The increased H3Ac at the proximal promoters of Oct4 and Sox2 observed in Rb mutant cells by ChIP-qPCR ( Figure S5A ) corresponded to a significant decrease of HDAC recruitment to these loci ( Figures 5G and 5H ). It should be noted, however, that the change in H3Ac at the proximal promoters of Oct4 and Sox2 was not identified by ChIP-eq, presumably due to the low levels of this mark escaping detection when analyzed on a genomic scale. Finally, because p27 was reported to repress Sox2 , we determined p27 localization at the DNA in wild-type, p130 −/− ; p107 −/− , and Rb family TKO MEFs. We found p27 binding to the downstream enhancer of Sox2 even in the absence of p130 and p107, but not in the TKO MEFs, indicating that the recruitment of p27 at the Sox2 locus can also be mediated by Rb ( Figure S5F ).
Rb Functionally Regulates Oct4 and Nanog, and Its Loss Can Functionally Replace Sox2 in Reprogramming
While the levels of derepression of pluripotency genes observed in Rb-deficient fibroblasts are small, we wondered if they may be sufficient to bypass the need for exogenous reprogramming factors. We infected Oct4-Neo R MEFs with three-factor combinations of the reprogramming factors and a hairpin against Rb. With just Oct4, Klf4, and c-Myc, several neomycin-resistant clones were readily obtained in Rb knockdown cells, but not in control cells. Fewer clones were observed with Oct4 and Klf4 alone in the Rb knockdown than with c-Myc or all four factors ( Figure S6A and S6B) . No iPSC colonies were observed when either Klf4 or Oct4 were omitted. These Rb KD OKM clones, in which the absence of Sox2 transgene was verified ( Figure S6C and S6D) , had a similar morphology to that of iPSCs reprogrammed with the four factors and expressed endogenous Oct4, Sox2, Nanog, and AP activity ( Figure 6A ). Additionally the Rb-deficient iPSCs reprogrammed without Sox2 formed teratomas with all three germ layers ( Figure S6E ) and contributed to a host embryo forming chimeric mice ( Figure S6F ). Thus, acute loss of Rb can functionally replace Sox2 during iPSC reprogramming.
To determine whether Rb could control the expression of pluripotency factors beyond Sox2, using another system, we tested if Rb loss might prime Oct4 and Nanog for activation. We employed the CRISPR-on approach (Cheng et al., 2013) to directly target the transcriptional activator VP64 to the Oct4 and Nanog promoters and observed a significantly enhanced expression from these genes when Rb was absent ( Figure 6B ). Therefore, while Rb loss did not compensate for exogenous Oct4 to generate fully reprogrammed iPSCs, Rb regulates the Oct4 locus physiologically.
Sox2 Is Required for the Development of Tumors Initiated by Loss of Rb
Based on emerging evidence that Sox2 plays oncogenic roles (Lu et al., 2010; Rudin et al., 2012) , we determined if the derepression of Sox2 observed in Rb-deficient cells might be relevant to cancer initiation. To test this idea, we crossed Rosa26 CreER Rb lox/lox mice to Sox2 lox/lox mice. As expected (Jacks et al., 1992) , we observed a significantly enlarged pituitary at 9 weeks after tamoxifen injection in Rosa26 CreER Rb lox/lox mice. Strikingly, concomitant loss of Sox2 completely blocked this cancer phenotype ( Figures 6C and 6D) , independent of gender ( Figure S6G and S6H) . Accordingly, loss of Sox2 completely inhibited cell proliferation in the pituitary of Rb-mutant mice ( Figures 6E and 6F , Figure  S6I ). These experiments indicate that Sox2 is critical for cancer initiation upon loss of Rb in the mouse pituitary gland.
DISCUSSION
The retinoblastoma tumor suppressor Rb is commonly inactivated in human cancer. While Rb has been extensively studied, its mechanisms of action remain incompletely understood. Here, using iPSC reprogramming as a cellular system, we identified a new facet of Rb tumor suppressor function in which Rb restricts the expression of pluripotency genes and their downstream targets, thereby preventing cellular dedifferentiation and transformation.
The degree of Rb involvement in direct regulation of pluripotency genes and downstream targets is particularly noteworthy. Although on the individual gene level, the transcriptional changes in pluripotency networks observed after Rb inactivation are subtle, a sizeable number of genes are affected. The genome-wide summation of these individually small effects results in a global transcriptionally permissive state and could explain the increased cell pliability of Rb-deficient cells that was observed before (Calo et al., 2010; McEvoy et al., 2011) . In fact, that low levels of pluripotency genes, particularly Sox2, may have strong phenotypic effects is not surprising because iPSCs often have few genomic integrations of Sox2 proviruses (Meissner et al., 2007; Wernig et al., 2007) , and low Sox2 is in fact favorable for high-quality iPSCs (Carey et al., 2011) . Our findings also provide a molecular basis for related cellular phenotypes directly or indirectly involving Rb and previously assumed to be caused by changes in the cell cycle (Banito et al., 2009; Li et al., 2010; Liu et al., 2009) . Notably, the effect on reprogramming was specific for Rb and was not observed for the closely related genes p107 and p130. Much like Rb, both of these factors restrict cell cycle progression (Dannenberg et al., 2000; Sage et al., 2000) , yet are rarely mutated in cancer. Therefore, the unique ability of Rb among its family members to suppress dedifferentiation may provide an explanation for its crucial role in suppressing cancer formation while its cell cycle checkpoint role is compensated more potently by the usually intact p107 and p130 proteins.
We found that the regulation of target genes by Rb correlates with the recruitment of histone modifying complexes and the subsequent regulation of histone marks. While loss of Rb resulted in increases of H3Ac and H3K4me3 at cell cycle genes, pluripotency genes, including Oct4, Sox2, and Nanog, mostly gained H3Ac and lost H3K27me3. This effect of Rb loss on pluripotency genes therefore more likely represents a derepression resulting in increased basal transcription rather than full activation, which is associated with robust promoter H3K4me3. While this derepression is general to pluripotency genes, we know that not all genes respond to the same degree because the increase of total expression of Sox2 is markedly higher than that of Oct4, and Rb loss could only replace Sox2 and not Oct4 to derive iPSCs. This may be explained by additional regulatory mechanisms restricting Oct4 expression, including high levels of DNA methylation at the Oct4 locus (Mikkelsen et al., 2008) , or a lack of LIN28 + regulation of Oct4 mRNA in MEFs (Qiu et al., 2010) . Nevertheless, loss of Rb enhances the expression of both Oct4 and Nanog when forced by a strong transcriptional activator, supporting a direct role for Rb in the regulation of these genes. Additional evidence linking cell cycle regulators to pluripotency genes is starting to emerge. For instance, the Cdk2 inhibitor p27 also controls the pluripotency of ESCs by direct inhibition of Sox2 ) (see also below). This regulation is mediated by the same enhancer that we found to be bound and regulated by Rb, suggesting possible interactions between p27 and Rb on the chromatin. Future studies may elucidate whether such interactions exist genome-wide or are specific for this enhancer.
While we observed changes in the chromatin landscape of MEFs after Rb loss, we expected that perturbation of the LxCxE binding cleft would have a reprogramming phenotype similar to loss of Rb. Mice harboring these knockin mutations have shown defects in chromatin modifications in other settings (Bourgo et al., 2011; Talluri et al., 2010) . However, our data show that interactions through this surface are not required for the silencing of Sox2 and Oct4. This is consistent with reports that in differentiated tissues, Rb-dependent silencing is normal in LxCxE mutant mice Talluri et al., 2010) . Furthermore, a dominant-negative DP1 (which blocks E2F transactivation) can rescue increased acetylation observed upon Rb loss . This presents two models whereby Rb might regulate heterochromatin. First, HDACs interact with Rb in LxCxE-in-dependent ways, so the longstanding model of direct HDAC recruitment is correct but at least partly LxCxE independent. Alternatively, Rb repression of E2Fs allows HDAC recruitment through other neighboring contacts. In this way, the effects on chromatin are genetically Rb dependent but the biochemical mechanism is distinct from simply being recruited by Rb. Regardless of which paradigm explains our data, E2F appears to be central to the mechanism of Rb regulation of Sox2 and Oct4.
Regulation of Sox2 at its upstream enhancer by the Rb family/ E2F and at its downstream enhancer by p21 has already been shown to direct the fate choices of neural stem cells (Julian et al., 2013; Marqués-Torrejón et al., 2013) . We observe that Rb represses Sox2 at its downstream, pluripotency-specific enhancer as cells differentiate. Moreover, the loss of this repression in the pituitary induces hyperplasia in a Sox2-dependent manner. It is noteworthy that Sox2 is expressed in the retina , in which loss of Rb is tumor initiating. Amplification of Sox2 has also been shown to be a driver mutation in human small cell lung cancer, a cancer initiated by loss of RB and p53 (Rudin et al., 2012) . Although inactivation of Rb, by either mutation or repression, is common to nearly all cancers, it is only initiating in a few cell types. This difference may rely in part on the initiating cell's ability to reactivate Sox2 transcriptional networks. The extent by which Rb regulation of Sox2 limits tumors in humans is still unknown, but our observations support the idea that cellular reprogramming assays can be used as a cellular system to probe the molecular mechanisms of cancer initiation.
EXPERIMENTAL PROCEDURES Cell Lines
The cell lines used were as follows: Rb lox/lox (cKO), Oct4-GFP +/− , Oct4-Neo +/− , B6;129S-Sox2 tm2Hoch /J (Sox2-GFP) and M2rtTA +/− ;Oct4-GFP +/− (Brambrink et al., 2008; Burkhart et al., 2010a; Meissner et al., 2007; Wernig et al., 2007) . Rb1 ΔL/ΔL MEFs have been reported previously (Isaac et al., 2006) . Rb1 ΔG/ΔG MEFs express an R461E, K542E mutant and its properties have previously been reported (Cecchini and Dick, 2011; Cecchini et al., 2014) .
Reprogramming and Differentiation Assays
For the 96-well efficiency assays, shRNA-infected cells were selected by 3 days of growth in puromycin, infected with the 4F, and plated at a density of 100 cells per well into 96-well plates containing 1,000 g-irradiated feeder cells per well. Wells with AP + cells and proper morphology (after 15 days) were reported to remove potential contribution of the seeding of daughter colonies. EBs were formed when we plated trypsinized ESCs in nonadherent plates at a density of 5.5 × 10 5 cells/ml in DMEM with 10% serum. After 3 days they were plated onto gelatin-coated tissue culture plates. After 5 days they were maintained in serum free conditions.
CFSE Analysis
CFSE staining was performed using the CellTrace™ Violet Cell Proliferation Kit (Invitrogen #C34557). Cells were trypsinized and washed with PBS, and then CFSE was added to 5 µM. They were incubated in the dark at 37°C for 20 min and then the reaction was quenched with media for 5 min. The cells were then washed, cultured, and later analyzed by FACS.
RNA and ChIP Sequencing
ChIP was performed as previously described (Burkhart et al., 2010b) . Antibodies are listed in Table S5 . Sequencing libraries were generated using the NEBNext DNA Sample Prep Master Mix Set (New England Biolabs) and purified using Agencourt Ampure XP beads (Beckman Coulter). Library quality was assessed on an Agilent 2100 Bioanalyzer and sequenced to generate single-end 50 bp reads using the Illumina HiSeq platform. We analyzed ChIP data by mapping the reads using Bowtie2 and identified peaks using MACS2 for the histone ChIP sequencing and CisGenome for the Rb ChIP. For expressional profiling, purified RNA was processed into cDNA with the Ovation RNA-Seq System V2 (NuGEN) and sonicated using a Covaris S2 Sonicator. RNA sequencing data were analyzed with the Tuxedo suite. H3K4me3 breadth remodeling was performed as previously described (Benayoun et al., 2014) . See Supplemental Experimental Procedures for additional information.
Pituitary Sectioning and Staining
To isolate the pituitary, we fixed the whole head overnight in Bouin's Fixative, removed it, fixed it overnight in 4% paraformaldehyde, and then dehydrated it in 70% ethanol. Antigen retrieval on the sections was performed using the Trilogy solution (Cell Marque) for 15 min in a pressure cooker. The sections were then washed in PBS + Tween20 (PBST) and fixed for 1 hr in PBST with 10% normal horse serum (NHS). They were incubated with Ki67 antibody (Table S5 ) overnight at 4°C in PBST with 5% NHS. After being washed in PBS, they were incubated with the secondary antibody in PBS with 5% NHS. Sections were then washed with PBS, stained with DAPI, and mounted. We identified cells by using CellProfiler (http://www.cellprofiler.org) to count nuclei on the DAPI channel, while Ki67 was scored manually in a blinded manner.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. subjected to the 4F (see Experimental Procedures). Significance was assessed by a t test to the 4F-infected sample (n ≥ 3). (C) Efficiency of iPSC formation was tested using Oct4-Neo R MEFs followed by treatment with G418 on day 15 and AP staining after 5 days of selection. Significance was assessed by a t test to the 4F sample.
(D) Efficiency of iPSC formation was tested using cKO MEFs stained for AP activity and Nanog expression to identify iPSC colonies. Significance was assessed by a t test (n = 3). (E) Efficiency of iPSC formation was tested with Rb overexpression by infection with AdRb-GFP or Ad-GFP. Significance was assessed by a t test (n = 2).
(F) Efficiency was tested for Rb knockdown MEFs and knockout MEFs for each of the pocket proteins. Significance was assessed by a t test to the 4F sample (n ≥ 3).
(G) Kinetics of reprogramming was determined by infecting shRb-infected Oct4-GFP MEFs with 4F. Plates were scored by the earliest GFP + colony appearance up to day 20. Significance was assessed by a t test comparing the controls against the three shRb hairpins (n ≥ 3).
(H) Analysis of early reprogramming events by SSEA1 expression in shRb (M) or control (C) infected MEFs 4 and 6 days after 4F (n = 3).
(I) Dox-dependence assay where shRb-infected Oct4-GFP MEFs were infected with 4F on day 0 and treated with Dox on day 1. The cells were switched to Dox-free media at regular intervals and GFP + colonies were screened on day 15 (n ≥ 3). All plots, unless noted, display the mean ± SD where *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S1 .
(D) Percent apoptosis as determined by Annexin V staining of Oct4-GFP MEFs either 4 or 6 days after 4F infection (n = 3). (E) Number of generations (Gen) after 4F evaluated by CFSE staining of shRb-infected MEFs. MEFs were infected with 4F on day 0 and stained with CFSE on day 1. On days 4 or 6, the cells were stained with anti-SSEA1 and analyzed by FACS. The gray curve represents CFSE-stained MEFs grown in 0.5% serum to induce quiescence. The black and the blue curves represent the CFSE histogram for the SSEA1 + control or shRb samples, respectively (n = 3). All plots display the mean ±SD unless noted where *p < 0.05. See also Figure S2 . (C) or GFP (G) followed by infection with an empty puromycin-selectable lentivirus (P) or the 4F. k-means clustering ( Figures S3C and S3D ) was first performed to divide the genetic expression levels that go up upon 4F expression (Cluster I), down (Cluster III), or remain unchanged (Cluster II) (G4F versus GP). Each of these clusters was then further divided by whether they change after loss of Rb (G4F versus C4F). Genes of interest are annotated on the left and are marked red, blue, or black depending on whether their expression levels go up, down, or stay unchanged, respectively, in the C4F set (upon loss of Rb). See also Table S1 . (B) GSEA profiles comparing the G4F and C4F set to expression profiles of matched MEF and iPSCs (Table S1 ). The green graph shows the running enrichment score for the gene set as it is calculated running down the genes from the RNA sequencing ( Figure 4A ) that are ranked by their enrichment in either the G4F or C4F sets (red/ blue heatmap). Normalized enrichment scores (NESs) and false discovery rates (FDRs) for the gene sets are reported. All plots display the mean ± SD where *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S3 . (Table S4 ). Significance was assessed by an unpaired t test to the average of the Ad-Cre-infected MEFs, including the mESC sample (n = 2). (B) Rb (blue) binding at Sox2, Oct4, and Mcm7. Enrichment is shown as the log 2 value of the fold change between normalized ChIP and the input samples (n = 2). The transcription start sites (TSS) are noted. Figure 5F , shown for the SRR1 and SRR2 enhancers, the PP, and the E1 of Sox2. All plots, unless noted, display the mean ± SD where *p < 0.05 and ***p < 0.001. See also Figure S5 . 
